138 related articles for article (PubMed ID: 31670104)
1. Development and validation of LC-MS/MS method for quantification of novel PP2A - β-catenin signalling inhibitor, S011-2111 in mice plasma: Application to its preclinical pharmacokinetic studies.
Riyazuddin M; Husain A; Valicherla GR; Verma S; Gupta AP; Praveena KS; Singh A; Avula SR; Sashidhara KV; Datta D; Gayen JR
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Nov; 1130-1131():121829. PubMed ID: 31670104
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of pharmacokinetics of novel DNA ligase I inhibitor, S012-1332 in rats: Integration of in vitro and in vivo findings.
Riyazuddin M; Valicherla GR; Husain A; Hussain MK; Shukla M; Katekar R; Gupta AP; Singh P; Banerjee D; Hajela K; Gayen JR
J Pharm Biomed Anal; 2019 Jan; 162():205-214. PubMed ID: 30265980
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.
Deng G; Liu W; Ma C; Rong X; Zhang Y; Wang Y; Wu C; Cao N; Ding W; Guan H; Cheng X; Wang C
J Ethnopharmacol; 2019 May; 236():288-301. PubMed ID: 30872168
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development.
Magotra A; Sharma A; Gupta AP; Wazir P; Sharma S; Singh PP; Tikoo MK; Vishwakarma RA; Singh G; Nandi U
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():200-206. PubMed ID: 28623772
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a highly sensitive LC-MS/MS-ESI method for quantification of IIIM-019-A novel nitroimidazole derivative with promising action against Tuberculosis: Application to drug development.
Kour G; Chandan BK; Khullar M; Munagala G; Singh PP; Bhagat A; Gupta AP; Vishwakarma RA; Ahmed Z
J Pharm Biomed Anal; 2016 May; 124():26-33. PubMed ID: 26922579
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an LC-MS/MS method for the determination of a novel thienoquinolin urea transporter inhibitor PU-48 in rat plasma and its application to a pharmacokinetic study.
Zhang ZY; Wang X; Liu D; Zhang H; Zhang Q; Lu YY; Li P; Lou YQ; Yang BX; Lu C; Lou YX; Zhang GL
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193233
[TBL] [Abstract][Full Text] [Related]
7. Validation of an LC-ESI-MS/MS method for the determination of apalutamide, a novel non-steroidal anti-androgen in mice plasma and its application to a pharmacokinetic study in mice.
Hallur G; Purra BR; Sulochana SP; Saini NK; Daram P; Zainuddin M; Mullangi R
J Pharm Biomed Anal; 2018 May; 153():260-266. PubMed ID: 29518645
[TBL] [Abstract][Full Text] [Related]
8. A validated enantioselective LC-MS/MS assay for quantification of a major chiral metabolite of an achiral 11-β-hydroxysteroid-dehydrogenase 1 inhibitor in human plasma: Application to a clinical pharmacokinetic study.
Furlong MT; Ji QC; Iacono L; Dang O; Noren M; Bruce J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():167-172. PubMed ID: 27100678
[TBL] [Abstract][Full Text] [Related]
9. LC-MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies.
Verma S; Goand UK; Garg R; Husain A; Katekar RA; Riyazuddin M; Dadge S; Gayen JR
Bioanalysis; 2023 Jan; 15(2):83-98. PubMed ID: 36916612
[TBL] [Abstract][Full Text] [Related]
10. Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study.
Lou Y; Hu H; Liu Y; Yu Q; Li L; Ping L; Yu L; Jiang H; Zeng S
J Pharm Biomed Anal; 2011 Jul; 55(5):1163-9. PubMed ID: 21549539
[TBL] [Abstract][Full Text] [Related]
11. LC-ESI-MS/MS determination of copanlisib, a novel PI3K inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice.
Dittakavi S; Mullangi R
Biomed Chromatogr; 2019 Apr; 33(4):e4460. PubMed ID: 30536684
[TBL] [Abstract][Full Text] [Related]
12. In vitro phase I cytochrome P450 metabolism, permeability and pharmacokinetics of SB639, a novel histone deacetylase inhibitor in preclinical species.
Venkatesh PR; Goh E; Zeng P; New LS; Xin L; Pasha MK; Sangthongpitag K; Yeo P; Kantharaj E
Biol Pharm Bull; 2007 May; 30(5):1021-4. PubMed ID: 17473456
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitative estimation of new imiqualine leads with potent anticancer activities in rat and mouse plasma. Application to a pharmacokinetic study in mice.
Chouchou A; Marion B; Enjalbal C; Roques C; Cuq P; Bonnet PA; Bressolle-Gomeni FMM; Deleuze-Masquéfa C
J Pharm Biomed Anal; 2018 Jan; 148():369-379. PubMed ID: 29111492
[TBL] [Abstract][Full Text] [Related]
14. Application of a sensitive and specific LC-MS/MS method for determination of eriodictyol-8-C-β-d-glucopyranoside in rat plasma for a bioavailability study.
Qiu F; Fu S; Zhang X; Gong M; Wang M
Biomed Chromatogr; 2015 Feb; 29(2):220-5. PubMed ID: 24898607
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a liquid chromatography-electrospray ionization-tandem mass spectrometry method for the determination of urolithin C in rat plasma and its application to a pharmacokinetic study.
Bayle M; Roques C; Marion B; Audran M; Oiry C; Bressolle-Gomeni FMM; Cros G
J Pharm Biomed Anal; 2016 Nov; 131():33-39. PubMed ID: 27521987
[TBL] [Abstract][Full Text] [Related]
16. Validation of a chiral LC-MS/MS-ESI method for the simultaneous quantification of darolutamide diastereomers in mouse plasma and its application to a stereoselective pharmacokinetic study in mice.
Balaji N; Sulochana SP; Saini NK; A SK; Mullangi R
Biomed Chromatogr; 2018 May; 32(5):e4173. PubMed ID: 29315691
[TBL] [Abstract][Full Text] [Related]
17. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
[TBL] [Abstract][Full Text] [Related]
18. Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis.
Kour G; Kumar A; Singh PP; Sharma S; Bhagat A; Vishwakarma RA; Ahmed Z
Pulm Pharmacol Ther; 2016 Oct; 40():44-51. PubMed ID: 27457685
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and metabolism profiles of protostemonine in rat by liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Han H; Yang L; Ding Y; Ji G; Zhang T
J Pharm Biomed Anal; 2016 Jan; 117():266-75. PubMed ID: 26397206
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic, bioavailability, metabolism and plasma protein binding evaluation of NADPH-oxidase inhibitor apocynin using LC-MS/MS.
Chandasana H; Chhonker YS; Bala V; Prasad YD; Chaitanya TK; Sharma VL; Bhatta RS
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():180-8. PubMed ID: 25682338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
